KR20010108331A - 스핑고이드 염기 유도체 및 그의 용도 - Google Patents

스핑고이드 염기 유도체 및 그의 용도 Download PDF

Info

Publication number
KR20010108331A
KR20010108331A KR1020017011411A KR20017011411A KR20010108331A KR 20010108331 A KR20010108331 A KR 20010108331A KR 1020017011411 A KR1020017011411 A KR 1020017011411A KR 20017011411 A KR20017011411 A KR 20017011411A KR 20010108331 A KR20010108331 A KR 20010108331A
Authority
KR
South Korea
Prior art keywords
acid
sphingoid base
sphingoid
base derivative
derivative according
Prior art date
Application number
KR1020017011411A
Other languages
English (en)
Korean (ko)
Inventor
휴고 스트릭스트라
피터 지버트 웨버
Original Assignee
비이체 코이닝
코스모페름 베.파우
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 비이체 코이닝, 코스모페름 베.파우 filed Critical 비이체 코이닝
Publication of KR20010108331A publication Critical patent/KR20010108331A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/24Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020017011411A 1999-03-09 2000-03-09 스핑고이드 염기 유도체 및 그의 용도 KR20010108331A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99200700.5 1999-03-09
EP99200700 1999-03-09
PCT/EP2000/002191 WO2000053568A1 (en) 1999-03-09 2000-03-09 Sphingoid base derivatives and uses thereof

Publications (1)

Publication Number Publication Date
KR20010108331A true KR20010108331A (ko) 2001-12-07

Family

ID=8239966

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017011411A KR20010108331A (ko) 1999-03-09 2000-03-09 스핑고이드 염기 유도체 및 그의 용도

Country Status (6)

Country Link
EP (1) EP1159256A1 (de)
JP (1) JP2002539110A (de)
KR (1) KR20010108331A (de)
CN (1) CN1360567A (de)
BR (1) BR0009265A (de)
WO (1) WO2000053568A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002060405A1 (en) * 2001-01-29 2002-08-08 Cosmoferm B.V. Veterinary dermatologic composition comprising a sphingoid base and/or a sphingoid base derivative
EP1287815A1 (de) * 2001-08-31 2003-03-05 Cosmoferm B.V. Verwendung einer Sphingoidbase zur Inhibierung von Ceramidase-Aktivität
DE60117900D1 (de) * 2001-09-05 2006-05-11 Charmzone Co Phytosphingosinderivate mit Antitumorwirkung
FR2836630B1 (fr) * 2002-03-01 2004-07-09 Lvmh Rech Utilisation cosmetique de la phytosphingosine comme agent amincissant et compositions cosmetiques contenant de la phytosphingosine
AU2003224486A1 (en) * 2002-05-02 2003-11-17 Doosan Corporation Composition for treating cancer containing n,n-dimethylphytosphingosine
DE10255554A1 (de) 2002-11-28 2004-06-17 Goldschmidt Ag Emulgator-Wachs-Gele auf Wasserbasis
FR2855048B1 (fr) * 2003-05-19 2006-07-21 Oreal Composition comprenant un precurseur de ceramide a base phytosphingosine et un activeur de la voie des 4-hydroxylases, utilisation pour renforcer la fonction barriere de la peau
FR2855049B1 (fr) * 2003-05-19 2006-07-21 Oreal Composition comprenant un precurseur de ceramide a base 6-hydroxy-sphingenine et un activeur de la voie des 6-hydroxylases, utilisation pour renforcer la fonction barriere de la peau
KR101288776B1 (ko) 2011-12-07 2013-07-22 가톨릭대학교 산학협력단 신규한 피토스핑고신 유도체 및 이를 포함하는 염증성 피부질환과 피부과다각화증질환 예방 및 개선용 화장료 조성물
JP6559914B2 (ja) * 2016-04-04 2019-08-14 オキュソフト インコーポレイテッドOCuSOFT,Inc. 眼瞼衛生を維持するための組成物、キット及び方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1235162B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisosfingolipidi
US5190876A (en) * 1988-12-27 1993-03-02 Emory University Method of modifying cellular differentiation and function and compositions therefor
JP3594962B2 (ja) * 1992-04-03 2004-12-02 コスモフェルム ベースローテン フェンノートシャップ アミノアルコールの選択的n‐アシル化
WO1994021595A1 (en) * 1993-03-17 1994-09-29 Kao Corporation Amine derivative and dermatologic preparation containing the same
GB2323594A (en) * 1997-03-25 1998-09-30 Victor Martin 2-amino-alkanoic acid derivatives, 2-amino alcohols and diamines
US6147118A (en) * 1997-05-02 2000-11-14 Dsm N.V. Antimicrobial compositions for topical use

Also Published As

Publication number Publication date
WO2000053568A1 (en) 2000-09-14
CN1360567A (zh) 2002-07-24
BR0009265A (pt) 2001-11-20
JP2002539110A (ja) 2002-11-19
EP1159256A1 (de) 2001-12-05

Similar Documents

Publication Publication Date Title
JP3533218B2 (ja) 不飽和脂肪族ジカルボン酸
KR100541271B1 (ko) 국소적 사용을 위한 항균조성물
KR20010108331A (ko) 스핑고이드 염기 유도체 및 그의 용도
Sawer et al. The effect of cryptolepine on the morphology and survival of Escherichia coli, Candida albicans and Saccharomyces cerevisiae
Birkinshaw et al. Studies in the biochemistry of micro-organisms: Fumaryl-dl-alanine (fumaromono-dl-alanide), a metabolic product of Penicillium resticulosum sp. nov
CN112535181B (zh) 一种菊花精油微胶囊及其制备方法和应用
US20120208230A1 (en) Em-Lacquer Water Solution Mixed with Natural Component, Method for Preparing Fermented Anti-Oxidant Material Using the Same, and Method for Processing the Material
US5104901A (en) Method of preventing mycoplasma infection
KR20130114808A (ko) 콜라겐 천연 발효액을 포함하는 화장료 조성물
GB2126089A (en) Composition of matter containing imidazolidinyl urea and parabens
KR102450693B1 (ko) 락토바실러스 파라카제이 uos1 균주, 및 이를 포함하는 항균 조성물
Sutanti et al. The use of yellow kepok banana peel extract (musa paradisiaca L. var bluggoe) as an antibacterial for chronic periodontitis caused by porphyromonas gingivalis
CN113368001A (zh) 防腐剂的应用与防腐剂组合物及其应用
Ahuja et al. Effect of dental films containing amoxycillin and metronidazole on periodontal pathogens: microbiological response
WO1996035439A1 (de) Niedermolekularer wirkstoffextrakt aus hefen und verfahren zu seiner herstellung
WO2017113263A1 (zh) 木质醋酸菌发酵液作为化妆品组合物之新颖用途
Subianto et al. Antibacterial potential of butterfly Pea (Clitoria ternatea) towards Aggregatibacter actinomycetemcomitans in vitr
KR102227751B1 (ko) 오미자, 백리향 및 꽃향유의 추출 혼합물을 유효성분으로 함유하는 천연 방부대체제 및 이의 용도
US20240082125A1 (en) Use of a short chain fatty acid as antidandruff agent
JP2657883B2 (ja) シアタン誘導体及びこれを有効成分とする神経成長因子産生誘導剤並びに抗菌剤
Razooki et al. A study on cosmetic products marketed in Iraq: Microbiological aspect
CN107224408B (zh) 一种植物源广谱抗菌剂及其制备方法和应用
JPH0543445A (ja) 皮膚外用剤
JP3476498B2 (ja) 抗酸化剤および化粧料
CN116172986A (zh) D-柠檬烯在制备抗耐药菌药物中应用

Legal Events

Date Code Title Description
N231 Notification of change of applicant
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid